Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors

Details for Australian Patent Application No. 2008315950 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Halldin, Christer; Heinrich, Tobias; Gulyas, Balazs; Nag, Sangram; Brumby, Thomas; Thiele, Andrea; Lehmann, Lutz

Agent Davies Collison Cave

Pub. Number AU-A-2008315950

PCT Pub. Number WO2009/052970

Priority 07021042.2 26.10.07 EP

Filing date 14 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07B 59/00 (2006.01) Introduction of isotopes of elements into organic compounds

C07C 309/66 (2006.01) Sulfonic acids

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

22 April 2010 PCT application entered the National Phase

  PCT publication WO2009/052970 Priority application(s): WO2009/052970

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008315951-Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same

2008315941-Herbicidal combination